Rj. Cliftonbligh et al., 2 NOVEL MUTATIONS IN THE THYROTROPIN (TSH) RECEPTOR GENE IN A CHILD WITH RESISTANCE TO TSH, The Journal of clinical endocrinology and metabolism, 82(4), 1997, pp. 1094-1100
The TSH receptor is a G protein-coupled receptor that mediates the eff
ects of TSH in thyroid development, growth, and synthetic function. We
report here that a child with features of TSH resistance, including m
arkedly increased serum TSH concentrations and low normal thyroid horm
one levels, is a compound heterozygote for two novel mutations in the
TSH receptor gene. One allele has a G to A transition corresponding to
an arginine to glutamine change at codon 109 (R109Q) in the extracell
ular domain of the receptor. The other allele has a G to A transition
corresponding to a premature termination codon at tryptophan 546 (W546
X) in the fourth transmembrane segment. Each parent is heterozygous fo
r one mutation, and both parents have normal thyroid function. Cells t
ransiently transfected with the R109Q mutant exhibited reduced membran
e binding of[I-125]TSH and impaired signal transduction in response to
TSH. In contrast, the W546X mutant was nonfunctional, with negligible
membrane radioligand binding. Our findings indicate that a single nor
mal TSH receptor allele is sufficient for normal thyroid function, but
that the compound abnormality in the proband leads to TSH resistance.